glp-1 colorectal cancer death risk study november 2025 GLP-1s May Improve Colon Outcomes Could GLP-1 medications help slow
Description
Elashoff R
This dual-action drug targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Set a specific day and time for your weekly injection and treat it as non-negotiable
In another study, Palnaes et al
Some people report weight changes with lower doses, but results vary
